Observational Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. May 27, 2021; 13(5): 476-492
Published online May 27, 2021. doi: 10.4240/wjgs.v13.i5.476
Figure 4
Figure 4 Liver resection is better than transarterial chemoembolization for selected Barcelona Clinic Liver Cancer stage B and Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma ≥ 10 cm patients. A: Overall survival; B: Hepatocellular carcinoma-specific survival. Estimated with inverse-probability of treatment weighting (IPTW). BCLC: Barcelona Clinic Liver Cancer; TACE: Transarterial chemoembolization.